Ad is loading...
IQV
Price
$192.68
Change
-$10.26 (-5.06%)
Updated
Nov 15 closing price
87 days until earnings call
TMO
Price
$513.08
Change
-$19.94 (-3.74%)
Updated
Nov 15 closing price
73 days until earnings call
Ad is loading...

IQV vs TMO

Header iconIQV vs TMO Comparison
Open Charts IQV vs TMOBanner chart's image
IQVIA Holdings
Price$192.68
Change-$10.26 (-5.06%)
Volume$4.58M
CapitalizationN/A
Thermo Fisher Scientific
Price$513.08
Change-$19.94 (-3.74%)
Volume$3.95M
CapitalizationN/A
IQV vs TMO Comparison Chart
Loading...
IQV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
IQV vs. TMO commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IQV is a Sell and TMO is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (IQV: $192.68 vs. TMO: $513.08)
Brand notoriety: IQV: Notable vs. TMO: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IQV: 325% vs. TMO: 289%
Market capitalization -- IQV: $45.3B vs. TMO: $220.19B
IQV [@Medical Specialties] is valued at $45.3B. TMO’s [@Medical Specialties] market capitalization is $220.19B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IQV’s FA Score shows that 0 FA rating(s) are green whileTMO’s FA Score has 0 green FA rating(s).

  • IQV’s FA Score: 0 green, 5 red.
  • TMO’s FA Score: 0 green, 5 red.
According to our system of comparison, TMO is a better buy in the long-term than IQV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IQV’s TA Score shows that 4 TA indicator(s) are bullish while TMO’s TA Score has 4 bullish TA indicator(s).

  • IQV’s TA Score: 4 bullish, 5 bearish.
  • TMO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TMO is a better buy in the short-term than IQV.

Price Growth

IQV (@Medical Specialties) experienced а -12.11% price change this week, while TMO (@Medical Specialties) price change was -7.01% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

IQV is expected to report earnings on Feb 12, 2025.

TMO is expected to report earnings on Jan 29, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TMO($220B) has a higher market cap than IQV($45.3B). TMO has higher P/E ratio than IQV: TMO (37.38) vs IQV (34.14). TMO YTD gains are higher at: -3.146 vs. IQV (-16.726). TMO has higher annual earnings (EBITDA): 11.1B vs. IQV (3.26B). TMO has more cash in the bank: 8.08B vs. IQV (1.5B). IQV has less debt than TMO: IQV (13.9B) vs TMO (34.9B). TMO has higher revenues than IQV: TMO (42.9B) vs IQV (15B).
IQVTMOIQV / TMO
Capitalization45.3B220B21%
EBITDA3.26B11.1B29%
Gain YTD-16.726-3.146532%
P/E Ratio34.1437.3891%
Revenue15B42.9B35%
Total Cash1.5B8.08B19%
Total Debt13.9B34.9B40%
FUNDAMENTALS RATINGS
IQV vs TMO: Fundamental Ratings
IQV
TMO
OUTLOOK RATING
1..100
5652
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
6035
SMR RATING
1..100
4260
PRICE GROWTH RATING
1..100
6463
P/E GROWTH RATING
1..100
8759
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TMO's Valuation (64) in the Medical Specialties industry is in the same range as IQV (70) in the Servicestothe Health Industry industry. This means that TMO’s stock grew similarly to IQV’s over the last 12 months.

TMO's Profit vs Risk Rating (35) in the Medical Specialties industry is in the same range as IQV (60) in the Servicestothe Health Industry industry. This means that TMO’s stock grew similarly to IQV’s over the last 12 months.

IQV's SMR Rating (42) in the Servicestothe Health Industry industry is in the same range as TMO (60) in the Medical Specialties industry. This means that IQV’s stock grew similarly to TMO’s over the last 12 months.

TMO's Price Growth Rating (63) in the Medical Specialties industry is in the same range as IQV (64) in the Servicestothe Health Industry industry. This means that TMO’s stock grew similarly to IQV’s over the last 12 months.

TMO's P/E Growth Rating (59) in the Medical Specialties industry is in the same range as IQV (87) in the Servicestothe Health Industry industry. This means that TMO’s stock grew similarly to IQV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IQVTMO
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
62%
Momentum
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
62%
MACD
ODDS (%)
Bearish Trend 3 days ago
57%
Bearish Trend 3 days ago
49%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 3 days ago
57%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
60%
Advances
ODDS (%)
Bullish Trend 12 days ago
63%
Bullish Trend about 1 month ago
62%
Declines
ODDS (%)
Bearish Trend 3 days ago
59%
Bearish Trend 3 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
72%
Aroon
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 3 days ago
60%
View a ticker or compare two or three
Ad is loading...
IQV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TMO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MYE11.70-0.03
-0.26%
Myers Industries
VRSN180.88-3.48
-1.89%
VeriSign
INBX13.83-0.50
-3.49%
Inhibrx Biosciences Inc.
HIMS19.32-1.53
-7.34%
Hims & Hers Health
TRAW4.99-0.59
-10.59%
Traws Pharma Inc

IQV and

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
-5.06%
CRL - IQV
73%
Closely correlated
-4.65%
ICLR - IQV
64%
Loosely correlated
-5.19%
TMO - IQV
60%
Loosely correlated
-3.74%
BRKR - IQV
57%
Loosely correlated
-5.85%
MEDP - IQV
54%
Loosely correlated
-7.23%
More

TMO and

Correlation & Price change

A.I.dvisor indicates that over the last year, TMO has been closely correlated with A. These tickers have moved in lockstep 79% of the time. This A.I.-generated data suggests there is a high statistical probability that if TMO jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TMO
1D Price
Change %
TMO100%
-3.74%
A - TMO
79%
Closely correlated
-2.42%
DHR - TMO
78%
Closely correlated
-3.71%
WAT - TMO
76%
Closely correlated
-4.85%
MTD - TMO
67%
Closely correlated
-4.70%
RVTY - TMO
63%
Loosely correlated
-5.63%
More